Prescrire Int. 2009 Dec;18(104):250.
When lifestyle measures and antacids are inadequate, and when no alarm symptoms are present, pantoprazole has a better risk-benefit balance than H2 receptor agonists.
当生活方式调整和抗酸剂治疗效果不佳,且不存在警示症状时,泮托拉唑的风险效益比优于H2受体激动剂。